For press inquiries click here to contact us.
Adaptive Biotechnologies Corporation
Adaptive Biotechnologies stock soars 90% after ringing Nasdaq opening bell following $300M IPO
Inscripta
Inscripta Looks to Combine CRISPR, Single-Cell Genomics, Synthetic Biology in New Platform
insitro
With $150M and a new NASH discovery deal with Gilead, AI star Daphne Koller has set out to change the drug R&D world
Alder Biopharmaceuticals, Inc.
Alder BioPharmaceuticals raises $170M in stock offering as FDA reviews its migraine therapy
Audentes, Inc.
Audentes Therapeutics to develop gene therapies for two types of muscular dystrophy, including Duchenne
Xconomy
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases
Xconomy
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy
FierceBiotech
MedTech FierceMedTech’s 2018 Fierce 15
Reuters
UniQure gene therapy shows promising result in mid-stage trial
Please see important disclaimers in the Terms section.
